clenbuterol has been researched along with Asthma in 39 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined the inhibitory effect of the long-acting beta-adrenergic agonists, mabuterol, clenbuterol and fenoterol on "morning dipping" in ten patients with nocturnal asthma." | 9.06 | [The inhibitory effect of long-acting beta-adrenergic agonists, mabuterol, clenbuterol and fenoterol on "morning dipping" in patients with asthma]. ( Dohi, Y; Maruo, H; Nagata, M; Sakamoto, Y; Suzuki, S; Tabe, K; Yamamoto, H; Yamamoto, K, 1990) |
| "Clenbuterol (C), a long-acting beta 2-selective bronchodilator was compared with salbutamol (S) in exercise-induced asthma (EIA) at two premedication time levels." | 9.06 | Comparison of the protective effect and duration of action of orally administered clenbuterol and salbutamol on exercise-induced asthma in children. ( Boner, AL; Brighenti, C; Miglioranzi, P; Richelli, C; Schiassi, M; Vallone, G, 1988) |
| "A study was carried out in 6 patients with bronchial asthma to investigate the effects of clenbuterol, a beta 2-sympathomimetic bronchodilator, on peripheral airway obstruction." | 9.05 | Effect of clenbuterol on peripheral airway obstruction in bronchial asthma. ( Chonan, T; Hida, W; Ichinose, M; Inoue, H; Kikuchi, Y; Sakurai, M; Shindoh, C; Takishima, T, 1985) |
| "A double-blind comparison between orally administered NAB 365 (clenbuterol) and salbutamol was conducted in 30 impatients with either asthma or chronic bronchitis with asthma who had at least 15% reversibility in airway obstruction following inhalation of 1,500 microgram of orciprenaline." | 9.04 | NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial. ( Capra, A; Pasotti, C; Vibelli, C, 1979) |
| "The effect of clenbuterol (NAB 365) in inhibiting exercise-induced asthma was compared with that of salbutamol in a single-blind, placebo-controlled, crossover study." | 9.04 | Aerosolized clenbuterol (NAB 365) and salbutamol in exercise-induced asthma. ( Del Bono, N; Quartieri, F; Vibelli, C, 1979) |
| "Seventy-five patients with chronic cough received diagnostic bronchodilator therapy with oral clenbuterol hydrochloride for 6 days." | 7.76 | Antitussive effects of the leukotriene receptor antagonist montelukast in patients with cough variant asthma and atopic cough. ( Fujimura, M; Ishiura, Y; Kita, T; Myou, S; Nakao, S; Nakatsumi, Y; Nomura, S; Ogawa, H, 2010) |
| "The protective effect of clenbuterol on exercise-induced asthma was studied in 14 patients with aspecific bronchial hyperreactivity." | 7.67 | Study of the cardiovascular effects of clenbuterol in exercise-induced asthma. ( Cuccurullo, F; Di Gioacchino, M; Guglielmi, MD; Lo Medico, E; Mancini, M; Marzio, L; Mezzetti, A; Proietti Franceschilli, G, 1987) |
| "For clenbuterol, the same was also observed in comparison with placebo, while for procaterol this was true only for FEV1 and FEF25-75, while no difference resulted from FVC and PEF." | 6.66 | Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma. ( Boner, AL; Castellani, C; Schiassi, M; Sette, L, 1987) |
| "Clenbuterol is a beta 2-sympathomimetic bronchodilator." | 6.64 | A trial of clenbuterol in bronchial asthma. ( Anderson, G; Wilkins, E, 1977) |
| "We examined the inhibitory effect of the long-acting beta-adrenergic agonists, mabuterol, clenbuterol and fenoterol on "morning dipping" in ten patients with nocturnal asthma." | 5.06 | [The inhibitory effect of long-acting beta-adrenergic agonists, mabuterol, clenbuterol and fenoterol on "morning dipping" in patients with asthma]. ( Dohi, Y; Maruo, H; Nagata, M; Sakamoto, Y; Suzuki, S; Tabe, K; Yamamoto, H; Yamamoto, K, 1990) |
| "Clenbuterol (C), a long-acting beta 2-selective bronchodilator was compared with salbutamol (S) in exercise-induced asthma (EIA) at two premedication time levels." | 5.06 | Comparison of the protective effect and duration of action of orally administered clenbuterol and salbutamol on exercise-induced asthma in children. ( Boner, AL; Brighenti, C; Miglioranzi, P; Richelli, C; Schiassi, M; Vallone, G, 1988) |
| "Clenbuterol was compared to an aminophylline preparation in a double-blind crossover trial involving 47 patients with asthma and reversible airways obstruction." | 5.05 | Clenbuterol ("Spiropent'): a long-acting bronchodilator. ( Wheatley, D, 1982) |
| "A study was carried out in 6 patients with bronchial asthma to investigate the effects of clenbuterol, a beta 2-sympathomimetic bronchodilator, on peripheral airway obstruction." | 5.05 | Effect of clenbuterol on peripheral airway obstruction in bronchial asthma. ( Chonan, T; Hida, W; Ichinose, M; Inoue, H; Kikuchi, Y; Sakurai, M; Shindoh, C; Takishima, T, 1985) |
| "-butylamino)methyl]-3,5-dichlorobenzyl alcohol hydrochloride (clenbuterol-HCl NAB 365, Spiropent) in comparison to fenoterol HBr was tested in a doubleblind trial in 30 patients with asthma bronchiale." | 5.04 | [The bronchodilatory effect of fenoterol-HBr in comparison to the new beta2-bronchodilator (NAB 365, clenbuterol-HCl) (author's transl)]. ( Dorow, P, 1977) |
| "A double-blind comparison between orally administered NAB 365 (clenbuterol) and salbutamol was conducted in 30 impatients with either asthma or chronic bronchitis with asthma who had at least 15% reversibility in airway obstruction following inhalation of 1,500 microgram of orciprenaline." | 5.04 | NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial. ( Capra, A; Pasotti, C; Vibelli, C, 1979) |
| "In a single-blind, placebo-controlled, cross-over study, the effects of intravenous 20 micrograms NAB 365 (clenbuterol) and intravenous 250 microgram terbutaline were compared in nine asthmatic patients with bronchospasm induced by exercise." | 5.04 | Intravenous NAB 365 (clenbuterol) and terbutaline in exercise-induced bronchospasm (EIB). ( Del Bono, N; Quartieri, F; Vibelli, C, 1979) |
| "The acute bronchodilator effect of the beta 2-adrenoceptor agonist terbutaline was tested single-blind cross-over in out-patients with chronic obstructive airways disease (intrinsic asthma)." | 5.04 | [Lung function studies with the bronchodilator terbutaline]. ( Bonelli, J; Hitzenberger, G; Kaik, G; Laggner, A; Magometschnigg, D, 1979) |
| "The effect of clenbuterol (NAB 365) in inhibiting exercise-induced asthma was compared with that of salbutamol in a single-blind, placebo-controlled, crossover study." | 5.04 | Aerosolized clenbuterol (NAB 365) and salbutamol in exercise-induced asthma. ( Del Bono, N; Quartieri, F; Vibelli, C, 1979) |
| "The acute bronchodilator effect of the beta 2-adrenoceptor agonist terbutaline was tested single-blind cross-over in out-patients with chronic obstructive airways disease (intrinsic asthma)." | 4.76 | [Pulmonary function tests with the bronchodilator Terbutaline]. ( Bonelli, J; Hitzenberger, G; Kaik, G; Laggner, A; Magometschnigg, D, 1979) |
| "Seventy-five patients with chronic cough received diagnostic bronchodilator therapy with oral clenbuterol hydrochloride for 6 days." | 3.76 | Antitussive effects of the leukotriene receptor antagonist montelukast in patients with cough variant asthma and atopic cough. ( Fujimura, M; Ishiura, Y; Kita, T; Myou, S; Nakao, S; Nakatsumi, Y; Nomura, S; Ogawa, H, 2010) |
| " He was being treated for long-standing asthma with a beta2 stimulant, clenbuterol hydrochloride, and had experienced no asthma attack for 9 years." | 3.74 | Pulmonary edema after electroconvulsive therapy in a patient treated for long-standing asthma with a beta2 stimulant. ( Arai, H; Hatta, K; Ito, M; Kitajima, A; Usui, C, 2007) |
| "To understand the roles of autoantibodies to beta 2 adrenergic receptors in the pathogenesis of asthma, we investigated the positive chronotropic action of beta 2-selective adrenergic agonist, clenbuterol, on cultured neonatal rat cardiomyocytes." | 3.69 | [Detection of circulating autoantibodies to beta 2-adrenergic receptors in patients with asthma]. ( Wu, J; Yang, Y; Yin, K, 1997) |
| "The serum gamma-globulin fraction from patients with allergic bronchial asthma (8/8), in contrast to the fraction from nonatopic control subjects (10/10), was found to inhibit the positive chronotropic action of the beta 2-selective adrenergic agonist, clenbuterol, on pyruvate- or lactate-treated cultured neonatal rat heart myocytes." | 3.68 | Autoantibodies to beta 2-adrenergic receptors with antiadrenergic activity from patients with allergic asthma. ( Wallukat, G; Wollenberger, A, 1991) |
| "The protective effect of clenbuterol on exercise-induced asthma was studied in 14 patients with aspecific bronchial hyperreactivity." | 3.67 | Study of the cardiovascular effects of clenbuterol in exercise-induced asthma. ( Cuccurullo, F; Di Gioacchino, M; Guglielmi, MD; Lo Medico, E; Mancini, M; Marzio, L; Mezzetti, A; Proietti Franceschilli, G, 1987) |
| "Clenbuterol was administered via DDS and via conventional MDI in a randomized manner." | 2.66 | Effect of an aerosol delivery system on bronchodilator activity. ( Cacopardo, B; Crimi, N; Mistretta, A; Oliveri, R; Palermo, F; Polosa, R; Vancheri, C, 1989) |
| "For clenbuterol, the same was also observed in comparison with placebo, while for procaterol this was true only for FEV1 and FEF25-75, while no difference resulted from FVC and PEF." | 2.66 | Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma. ( Boner, AL; Castellani, C; Schiassi, M; Sette, L, 1987) |
| "Clenbuterol is a beta 2-sympathomimetic bronchodilator." | 2.64 | A trial of clenbuterol in bronchial asthma. ( Anderson, G; Wilkins, E, 1977) |
| " The characteristics of the oral route are easy usage, precise dosage and assured effects." | 1.27 | Oral beta 2-selective adrenergic bronchodilators. ( Daniotti, S; Dottorini, M; Grassi, V; Schiassi, M; Tantucci, C, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (79.49) | 18.7374 |
| 1990's | 5 (12.82) | 18.2507 |
| 2000's | 2 (5.13) | 29.6817 |
| 2010's | 1 (2.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimura, M | 2 |
| Kita, T | 1 |
| Ogawa, H | 1 |
| Nakatsumi, Y | 1 |
| Nomura, S | 1 |
| Ishiura, Y | 1 |
| Myou, S | 1 |
| Nakao, S | 1 |
| Hatta, K | 1 |
| Kitajima, A | 1 |
| Ito, M | 1 |
| Usui, C | 1 |
| Arai, H | 1 |
| Murai, T | 1 |
| Maejima, T | 1 |
| Sanai, K | 1 |
| Osada, E | 1 |
| Kawakami, Y | 1 |
| Agostini, M | 1 |
| Barlocco, G | 1 |
| Mastella, G | 1 |
| Yamada, Y | 1 |
| Kawai, T | 1 |
| Onaka, A | 1 |
| Kamo, T | 1 |
| Ajisawa, A | 1 |
| Pöch, G | 1 |
| Král, B | 1 |
| Jirkal, J | 1 |
| Eliás, J | 1 |
| Ilnerová, A | 1 |
| Dolezalová, K | 1 |
| Tilser, P | 1 |
| Keelan, P | 2 |
| Gray, P | 2 |
| Cox, GA | 2 |
| Villate Navarro, JI | 1 |
| Sobradillo Peña, V | 1 |
| Atxotegui Iraola-Goitia, V | 1 |
| Uresandi Romero, F | 1 |
| Sánchez García, J | 1 |
| Wheatley, D | 1 |
| Wang, GJ | 1 |
| Wu, J | 1 |
| Yin, K | 1 |
| Yang, Y | 1 |
| Dorow, P | 2 |
| Kaik, G | 2 |
| Bonelli, J | 2 |
| Hitzenberger, G | 2 |
| Laggner, A | 2 |
| Magometschnigg, D | 2 |
| Anderson, G | 1 |
| Wilkins, E | 1 |
| Cummiskey, J | 1 |
| Pasotti, C | 1 |
| Capra, A | 1 |
| Vibelli, C | 3 |
| Del Bono, N | 2 |
| Quartieri, F | 2 |
| Hou, SY | 1 |
| Miyata, T | 1 |
| Takahama, K | 1 |
| Hasanat, A | 1 |
| Ikegami, K | 1 |
| Iwasaki, K | 1 |
| Okano, Y | 1 |
| Kasé, Y | 1 |
| Palmer, JB | 1 |
| Shepherd, GL | 1 |
| Cifelli, AT | 1 |
| Wallukat, G | 1 |
| Wollenberger, A | 1 |
| Huszar, E | 1 |
| Herjavecz, I | 1 |
| Böszörmenyi-Nagy, G | 1 |
| Slapke, J | 1 |
| Schreiber, J | 1 |
| Debreczeni, LA | 1 |
| Yamamoto, H | 1 |
| Nagata, M | 1 |
| Tabe, K | 1 |
| Suzuki, S | 1 |
| Maruo, H | 1 |
| Sakamoto, Y | 1 |
| Yamamoto, K | 1 |
| Dohi, Y | 1 |
| Grassi, V | 1 |
| Daniotti, S | 1 |
| Schiassi, M | 3 |
| Dottorini, M | 1 |
| Tantucci, C | 1 |
| Chazan, R | 1 |
| Kokot, M | 1 |
| Droszcz, W | 1 |
| Crimi, N | 2 |
| Palermo, F | 2 |
| Cacopardo, B | 2 |
| Vancheri, C | 2 |
| Oliveri, R | 2 |
| Polosa, R | 1 |
| Mistretta, A | 2 |
| Boner, AL | 2 |
| Sette, L | 1 |
| Castellani, C | 1 |
| Vallone, G | 1 |
| Brighenti, C | 1 |
| Miglioranzi, P | 1 |
| Richelli, C | 1 |
| Osella, D | 1 |
| Giorgis, GE | 1 |
| Galietti, F | 1 |
| Miravalle, C | 1 |
| Ardizzi, A | 1 |
| Di Gioacchino, M | 1 |
| Mezzetti, A | 1 |
| Mancini, M | 1 |
| Guglielmi, MD | 1 |
| Lo Medico, E | 1 |
| Proietti Franceschilli, G | 1 |
| Marzio, L | 1 |
| Cuccurullo, F | 1 |
| Palermo, B | 1 |
| Hida, W | 1 |
| Sakurai, M | 1 |
| Ichinose, M | 1 |
| Shindoh, C | 1 |
| Chonan, T | 1 |
| Kikuchi, Y | 1 |
| Inoue, H | 1 |
| Takishima, T | 1 |
2 reviews available for clenbuterol and Asthma
| Article | Year |
|---|---|
[Causes of prolonged and chronic cough].
Topics: Adrenergic beta-Agonists; Albuterol; Androstadienes; Asthma; Chronic Disease; Clenbuterol; Cough; Dr | 2008 |
[Pulmonary function tests with the bronchodilator Terbutaline].
Topics: Administration, Oral; Adult; Aged; Albuterol; Asthma; Atropine; Clenbuterol; Epinephrine; Female; Fe | 1979 |
21 trials available for clenbuterol and Asthma
| Article | Year |
|---|---|
First clinical studies on mabuterol. A summarizing report.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Bronchodilator Agents; Cardiovascular System; Chronic Di | 1984 |
Protective effect of fenoterol spray, ipratropium bromide plus fenoterol spray, and oral clenbuterol, on exercise-induced asthma in children. Double blind controlled and randomized clinical trial.
Topics: Administration, Intranasal; Administration, Oral; Adolescent; Aerosols; Asthma; Asthma, Exercise-Ind | 1983 |
A multiple-dose response study of clenbuterol in bronchial asthma.
Topics: Adult; Asthma; Clenbuterol; Clinical Trials as Topic; Dose-Response Relationship, Drug; Ethanolamine | 1980 |
[Action of 3 beta-mimetic bronchodilators: clenbuterol, hexoprenaline, fenoterol. Comparative study].
Topics: Asthma; Bronchi; Bronchitis; Clenbuterol; Clinical Trials as Topic; Drug Evaluation; Ethanolamines; | 1980 |
Clenbuterol ("Spiropent'): a long-acting bronchodilator.
Topics: Adolescent; Adult; Aged; Aminophylline; Asthma; Clenbuterol; Clinical Trials as Topic; Double-Blind | 1982 |
[Long-term studies using a beta-2-mimetic Spiropent)].
Topics: Adult; Asthma; Bronchitis; Clenbuterol; Clinical Trials as Topic; Ethanolamines; Female; Humans; Lon | 1978 |
[The bronchodilatory effect of fenoterol-HBr in comparison to the new beta2-bronchodilator (NAB 365, clenbuterol-HCl) (author's transl)].
Topics: Adult; Aerosols; Asthma; Bronchodilator Agents; Clenbuterol; Clinical Trials as Topic; Ethanolamines | 1977 |
A trial of clenbuterol in bronchial asthma.
Topics: Adolescent; Adult; Aged; Albuterol; Asthma; Clenbuterol; Clinical Trials as Topic; Double-Blind Meth | 1977 |
Comparison of NAB 365 and salbutamol tablets in chronic bronchitis and asthma.
Topics: Adult; Aged; Albuterol; Asthma; Bronchitis; Chronic Disease; Clenbuterol; Clinical Trials as Topic; | 1978 |
NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial.
Topics: Adolescent; Adult; Aged; Albuterol; Asthma; Clenbuterol; Clinical Trials as Topic; Double-Blind Meth | 1979 |
Intravenous NAB 365 (clenbuterol) and terbutaline in exercise-induced bronchospasm (EIB).
Topics: Adolescent; Adult; Asthma; Asthma, Exercise-Induced; Blood Pressure; Clenbuterol; Ethanolamines; For | 1979 |
[Lung function studies with the bronchodilator terbutaline].
Topics: Adult; Aged; Airway Resistance; Asthma; Atropine; Clenbuterol; Drug Combinations; Ethylenediamines; | 1979 |
Aerosolized clenbuterol (NAB 365) and salbutamol in exercise-induced asthma.
Topics: Adolescent; Adult; Aerosols; Albuterol; Asthma; Child; Clenbuterol; Ethanolamines; Female; Hemodynam | 1979 |
[The inhibitory effect of long-acting beta-adrenergic agonists, mabuterol, clenbuterol and fenoterol on "morning dipping" in patients with asthma].
Topics: Administration, Oral; Adolescent; Adrenergic beta-Agonists; Adult; Asthma; Circadian Rhythm; Clenbut | 1990 |
[Bronchodilator and bronchial hyperreactivity-inhibiting effects of clenbuterol in patients with bronchial asthma].
Topics: Adult; Asthma; Bronchi; Bronchial Spasm; Clenbuterol; Clinical Trials as Topic; Ethanolamines; Femal | 1986 |
Effect of an aerosol delivery system on bronchodilator activity.
Topics: Adult; Aerosols; Asthma; Bronchodilator Agents; Clenbuterol; Evaluation Studies as Topic; Forced Exp | 1989 |
Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma.
Topics: Administration, Oral; Asthma; Bronchodilator Agents; Child; Clenbuterol; Double-Blind Method; Ethano | 1987 |
Comparison of the protective effect and duration of action of orally administered clenbuterol and salbutamol on exercise-induced asthma in children.
Topics: Administration, Oral; Albuterol; Altitude; Asthma; Asthma, Exercise-Induced; Child; Clenbuterol; Dou | 1988 |
[Double-blind study of the bronchodilating action of the aminophylline-clenbuterol combination in asthmatic patients].
Topics: Aged; Aminophylline; Asthma; Clenbuterol; Clinical Trials as Topic; Double-Blind Method; Drug Therap | 1986 |
Bronchodilator effect of Aerochamber and Inspirease in comparison with metered dose inhaler.
Topics: Adult; Analysis of Variance; Asthma; Clenbuterol; Double-Blind Method; Ethanolamines; Forced Expirat | 1987 |
Effect of clenbuterol on peripheral airway obstruction in bronchial asthma.
Topics: Adolescent; Adult; Aged; Asthma; Blood Gas Analysis; Blood Pressure; Clenbuterol; Clinical Trials as | 1985 |
16 other studies available for clenbuterol and Asthma
| Article | Year |
|---|---|
Antitussive effects of the leukotriene receptor antagonist montelukast in patients with cough variant asthma and atopic cough.
Topics: Acetates; Adult; Aged; Antitussive Agents; Asthma; Clenbuterol; Cough; Cyclopropanes; Drug Therapy, | 2010 |
Pulmonary edema after electroconvulsive therapy in a patient treated for long-standing asthma with a beta2 stimulant.
Topics: Adrenergic beta-Agonists; Aged; Anesthesia, Intravenous; Asthma; Clenbuterol; Depressive Disorder, M | 2007 |
Pharmacological studies of mabuterol, a new selective beta 2-stimulant. I: Bronchodilating effect.
Topics: Acetylcholine; Adrenergic beta-Agonists; Airway Resistance; Animals; Asthma; Blood Gas Analysis; Blo | 1984 |
[Influence of sympathomimetic drugs on immediate intradermal reactions induced by allergens].
Topics: Adult; Albuterol; Asthma; Clenbuterol; Ethanolamines; Humans; Hypersensitivity, Immediate; Intraderm | 1984 |
[Initial values and drug effects].
Topics: Asthma; Bezafibrate; Blood Pressure Determination; Chlorthalidone; Cholesterol; Clenbuterol; Humans; | 1984 |
Spiropent in the treatment of reversible airways obstruction.
Topics: Adult; Asthma; Bronchitis; Child; Chronic Disease; Clenbuterol; Ethanolamines; Humans | 1982 |
[The anti-asthma effect of compound cycloclenbuterol on bronchial asthma (author's transl)].
Topics: Adolescent; Adult; Aminophylline; Asthma; Atropa belladonna; Child; Clenbuterol; Diphenhydramine; Dr | 1981 |
[Detection of circulating autoantibodies to beta 2-adrenergic receptors in patients with asthma].
Topics: Adrenergic beta-Antagonists; Adult; Animals; Animals, Newborn; Asthma; Autoantibodies; Cells, Cultur | 1997 |
[Evaluation of the antiasthmatic effect of Chuanliping (clenbuterol Co) aetocol (author's transl)].
Topics: Adrenergic beta-Agonists; Alkaloids; Asthma; Clenbuterol; Drug Combinations; Ethanolamines; Humans; | 1979 |
[Animal experiment and clinical observation on anti-bronchoasthma effect of clenbuterol (author's transl)].
Topics: Animals; Asthma; Clenbuterol; Ethanolamines; Female; Guinea Pigs; Humans; Male | 1979 |
[Action of 4-amino-alpha-](tertbutylamino) methyl]-3, 5-dichlorobenzylalchol hydrochloride (N-AB 365, clenbuterol) on the respiratory system (author's transl)].
Topics: Acetylcholine; Administration, Oral; Animals; Antitussive Agents; Asthma; Blood Pressure; Bronchodil | 1978 |
Muscling in on salbutamol.
Topics: Albuterol; Animals; Asthma; Clenbuterol; Delayed-Action Preparations; Doping in Sports; Humans; Musc | 1992 |
Autoantibodies to beta 2-adrenergic receptors with antiadrenergic activity from patients with allergic asthma.
Topics: Adult; Animals; Asthma; Autoantibodies; Autoimmunity; Cells, Cultured; Clenbuterol; Female; Heart Ra | 1991 |
Effects of ketotifen and clenbuterol on beta-adrenergic receptor functions of lymphocytes and on plasma TXB-2 levels of asthmatic patients.
Topics: Asthma; Clenbuterol; Cyclic AMP; Drug Therapy, Combination; Humans; Ketotifen; Lymphocytes; Receptor | 1990 |
Oral beta 2-selective adrenergic bronchodilators.
Topics: Administration, Oral; Adrenergic beta-Agonists; Aged; Asthma; Bronchodilator Agents; Child; Clenbute | 1986 |
Study of the cardiovascular effects of clenbuterol in exercise-induced asthma.
Topics: Adolescent; Adult; Asthma; Asthma, Exercise-Induced; Blood Pressure; Clenbuterol; Ethanolamines; Exe | 1987 |